Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:HTGC
NYSE:HTGCCapital Markets

A Look At Hercules Capital (HTGC) Valuation After Recent Share Price Weakness And Analyst Discount

Recent share performance and business profile Hercules Capital (HTGC) has traded around $15.57 recently, with the stock up about 2.3% on the latest day and modestly higher over the past week, while down roughly 6% over the past month. Over the past 3 months, the stock is up about 4.8%, while year to date it is down roughly 17.4% and about 2.5% lower over the past year on a total return basis. For a longer view, Hercules Capital shows total returns of roughly 42.5% over the past 3 years and...
TSX:EQX
TSX:EQXMetals and Mining

Does Equinox Gold’s (TSX:EQX) Quebec Risk Framework Reveal a Deeper Valuation Disconnect?

Equinox Gold Corp. recently presented at The Mining Investment Event + Core Shack in Quebec City, where Chief Strategy & Risk Officer Daniella Elena Dimitrov outlined the company’s outlook and risk framework. This comes amid mixed third‑party assessments of Equinox Gold’s valuation and operational challenges, highlighting contrasting models of the company’s underlying worth and risk profile. We’ll now examine how this recent conference appearance, set against conflicting valuation...
NYSE:COUR
NYSE:COURConsumer Services

Does Employer Demand For Micro-Credentials Change The Bull Case For Coursera (COUR)?

In late May 2026, Coursera released a report showing that most US employers are willing to pay higher starting salaries and see stronger first-year productivity for graduates holding industry micro-credentials. The same report indicated that a large majority of US graduates with these micro-credentials secured roles aligned to their field within a year, underscoring growing workforce relevance for this type of learning. We’ll now examine how this stronger employer appetite for industry...
XTRA:IFX
XTRA:IFXSemiconductor

Infineon Quantum Secure Nvidia Tie Up Fuels AI Hardware Rethink

Infineon Technologies (XTRA:IFX) has integrated its OPTIGA TPM SLB 9672 with NVIDIA's Jetson Thor platform. The collaboration targets hardware based, quantum resilient security for autonomous and robotics systems used in Physical AI. The solution is designed to support post quantum cryptographic protection and align with upcoming NIST standards. For investors watching Infineon Technologies at a share price of €85.05, this move highlights how the company is tying its security hardware to...
NYSE:BANC
NYSE:BANCBanks

Did Regional Bank Rally and Stable Margins Just Shift Banc of California's (BANC) Investment Narrative?

Earlier this week, Banc of California participated in a broad financial sector rally as regional banks drew renewed investor attention amid improving sentiment. Investors were particularly focused on the bank’s net interest margin setup, with stabilizing deposit costs and elevated loan yields supporting a more favorable earnings backdrop for regional lenders. We’ll now look at how this renewed focus on Banc of California’s net interest margin profile shapes its broader investment...
NYSE:BCO
NYSE:BCOCommercial Services

Assessing Brink’s (BCO) Valuation After Recent Share Price Weakness And Undervaluation Narrative

Brink's stock reaction and recent performance Brink's (BCO) has drawn investor attention after recent trading left the stock roughly flat over the past day. It has fallen about 6% over the past week and 14% in the past 3 months. See our latest analysis for Brink's. At around $100.94 per share, Brink's short term share price momentum has been weak, with the stock down over the past month and quarter, even as the 1 year total shareholder return of 22.22% and 3 year total shareholder return of...
NYSE:PM
NYSE:PMTobacco

Philip Morris Balances Zyn Ultra Growth With EU Illicit Trade Risks

Philip Morris International (NYSE:PM) has introduced Zyn Ultra nicotine pouches in the US, expanding its smoke free portfolio. The company is also warning about a rise in illicit cigarette consumption in the EU and calling for stronger enforcement. For you as an investor, these developments highlight both growth efforts and operational headwinds at NYSE:PM. The company has been pushing deeper into smoke free products, and Zyn Ultra adds another branded option in the US nicotine pouch...
NYSE:H
NYSE:HHospitality

Hyatt Taps Luxury All Inclusive Demand Loyalty And AI For Growth

Hyatt Hotels (NYSE:H) is drawing attention as its luxury all inclusive resorts report strong occupancy, reflecting solid demand for higher end leisure travel. The company is leaning on its World of Hyatt loyalty program with new engagement efforts, including exclusive live podcast events featuring its sports ambassadors. CEO Mark Hoplamazian has been publicly discussing the role of artificial intelligence and changing travel patterns, signaling how Hyatt is thinking about future operations...
NYSE:TSN
NYSE:TSNFood

Tyson Foods Summer Grill Push Tests Branded Growth And Valuation Gap

Tyson Foods launched a major range of summer products across its Tyson, Wright, Ball Park, and Hillshire Farm brands. The new line focuses on ready to enjoy options for grilling season, including first time and limited edition offerings. The refresh targets seasonal demand and consumer interest in branded, value added protein products. Tyson Foods (NYSE:TSN) is rolling out this expanded summer line as the stock trades at $56.88. The share price is up 6.6% over the past year, although it is...
NYSE:BIPC
NYSE:BIPCGas Utilities

Assessing Brookfield Infrastructure (BIPC) Valuation As Shares Rebound While Longer Term Returns Remain Mixed

Why Brookfield Infrastructure is on investor radars today Brookfield Infrastructure (BIPC) has drawn fresh attention following its recent share performance, with the stock up about 9% over the past month but down roughly 11% over the past 3 months. See our latest analysis for Brookfield Infrastructure. The recent 9.5% 1 month share price return contrasts with a 10.6% decline over 3 months and an 8.2% decline year to date. The 1 year total shareholder return of 5.8% suggests momentum has been...
NYSE:DOLE
NYSE:DOLEFood

Assessing Dole (NYSE:DOLE) Valuation After Recent Mixed Shareholder Returns

How Dole stock has been trading Dole (NYSE:DOLE) has traded with mixed returns recently, with the stock up 1.2% over the past day but down over the past week, month, past 3 months, and year to date. Over the past year, total return is 3.8%, with a 3 year total return of 8.1%. That sits against a recent closing share price of US$13.93 and a market value of about US$1.3b. See our latest analysis for Dole. Recent trading has been softer, with the share price down over the past month and quarter...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike (CRWD) Turns Quarterly Profit Challenging Skepticism Around Its Path To Earnings

CrowdStrike Holdings (CRWD) opened its Q1 2027 scorecard with revenue of about US$1.4 billion, basic EPS of US$0.11 and net income of US$27.8 million, setting a clear marker for how the stock’s US$719.09 share price lines up with its recent profitability. Over the past five reported quarters, revenue has moved from US$1.1 billion in Q1 2026 to about US$1.4 billion in Q1 2027, while basic EPS has shifted from a loss of US$0.42 to a gain of US$0.11 as net income moved from a loss of US$104.3...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Is Tractor Supply (TSCO) Pricing Looked At Differently After This Year’s Sharp Share Price Fall?

If you are wondering whether Tractor Supply's share price now reflects good value or just a value trap, the recent performance gives you plenty to think about. The stock closed at US$29.37, with the share price down 6.4% over the past week, down 10.1% over the past month, and down 42.2% year to date, contributing to a 41.7% decline over the last year and a 29.2% and 10.8% decline over the past 3 and 5 years respectively. These moves have kept Tractor Supply in focus for investors watching...
ASX:JDO
ASX:JDOBanks

ASX Penny Stock Highlights Featuring Black Cat Syndicate And Two Others

The Australian market is poised for a modest uptick, with ASX futures indicating a slight rise, reflecting mixed signals from Wall Street where the Dow Jones reached new heights. In such fluctuating conditions, investors often turn their attention to penny stocks—companies that may be smaller or newer but hold potential for significant value due to their affordability and growth prospects. Despite being an old term, penny stocks remain relevant today as they can offer opportunities when...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

Is It Too Late To Consider C.H. Robinson Worldwide (CHRW) After A 98% One Year Surge?

If you are wondering whether C.H. Robinson Worldwide at US$184.59 is priced for perfection or still offers value, it helps to step back and look at what the recent share performance and fundamentals are really telling you. The stock has returned 5.2% over the past week, 10.4% over the past month, 12.7% year to date, 97.6% over the last year, 117.0% over three years, and 108.7% over five years, which naturally raises questions about how much of the story is already reflected in the...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices Buy Of Empower Targets Bigger Role In AI Power

Analog Devices (NasdaqGS:ADI) announced a $1.5b deal to acquire Empower Semiconductor. The acquisition is aimed at expanding ADI's AI focused power management portfolio. The move is intended to deepen ADI's reach into AI infrastructure and data center power solutions. Analog Devices enters this transaction with the stock at $428.76 and very large multi year share gains, including a 99.3% return over the past year and 178.9% over five years. The company has also recorded a 56.6% return year...
NasdaqGM:OCS
NasdaqGM:OCSPharmaceuticals

Oculis Holding (OCS) Is Down 60.1% After OCS-01 Trial Failure And Pipeline Pivot – Has The Bull Case Changed?

Oculis Holding AG recently reported that its Phase 3 DIAMOND-1 and DIAMOND-2 trials of OCS-01 eye drops in diabetic macular edema failed to meet primary and key secondary visual acuity endpoints, leading the company to halt plans for an FDA filing in this indication. While vision-related endpoints fell short, the trials showed persistent reductions in retinal thickness and prompted Oculis to reallocate its strong US$278 million cash position toward advancing privosegtor in optic neuropathies...